Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth-Ann Coller

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Review of Vaccines|October 2, 2018
Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine programSwati B Gupta, Beth-Ann Coller, Mark Feinberg
Vaccine|June 29, 2011
The development of Dengue vaccines. IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Vaccine|November 25, 2015
IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Journal of Virological Methods|December 12, 2003
A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cellsAndré S Bachmann, Gloria Corpuz, Wade P Hareld, et al.
Vaccine|January 22, 2011
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccinesHeng Liu, Laura Bungener, Wouter ter Veer, et al.
NPJ Vaccines|June 23, 2020
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogensJayanthi Wolf, Samantha Bruno, Michael Eichberg, et al.
Journal of Wildlife Diseases|January 12, 2013
Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E)Susan I Jarvi, Darcy Hu, Kathleen Misajon, et al.
Vaccines|March 6, 2021
Development of Pandemic Vaccines: ERVEBO Case StudyJayanthi Wolf, Risat Jannat, Sheri Dubey, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2008
Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamstersMarina T Siirin, Amelia P A Travassos da Rosa, Patrick Newman, et al.
The Journal of Infectious Diseases|September 11, 2019
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsScott A Halperin, Rituparna Das, Matthew T Onorato, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Review of Vaccines|October 2, 2018
Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine programSwati B Gupta, Beth-Ann Coller, Mark Feinberg
Vaccine|June 29, 2011
The development of Dengue vaccines. IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Vaccine|November 25, 2015
IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Journal of Virological Methods|December 12, 2003
A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cellsAndré S Bachmann, Gloria Corpuz, Wade P Hareld, et al.
Vaccine|January 22, 2011
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccinesHeng Liu, Laura Bungener, Wouter ter Veer, et al.
NPJ Vaccines|June 23, 2020
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogensJayanthi Wolf, Samantha Bruno, Michael Eichberg, et al.
Journal of Wildlife Diseases|January 12, 2013
Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E)Susan I Jarvi, Darcy Hu, Kathleen Misajon, et al.
Vaccines|March 6, 2021
Development of Pandemic Vaccines: ERVEBO Case StudyJayanthi Wolf, Risat Jannat, Sheri Dubey, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2008
Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamstersMarina T Siirin, Amelia P A Travassos da Rosa, Patrick Newman, et al.
The Journal of Infectious Diseases|September 11, 2019
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsScott A Halperin, Rituparna Das, Matthew T Onorato, et al.
Pageof 2